The Best Trillion-Dollar Stock to Buy Right Now? Wall Street Has a Clear Answer for Investors.
Ten public companies have achieved a market value exceeding $1 trillion as of June 16. They are listed below in descending order based on upside implied by the median target price set by Wall Street analysts.
Nvidia (NASDAQ: NVDA) has a median target price of $175 per share. That implies 21% upside from its current share price of $145.
Apple has median target price of $235 per share. That implies 18% upside from its current share price of $198.
Broadcom has a median target price of $290 per share. That implies 15% upside from its current share price of $252.
Alphabet has a median target price of $200 per share. That implies 13% upside from its current share price of $177.
Amazon has a median target price of $240 per share. That implies 11% upside from its current share price of $216.
Microsoft has a median target price of $510 per share. That implies 6% upside from its current share price of $479.
Taiwan Semiconductor Manufacturing has a median target price of $225 per share. That implies 4% upside from its current share price of $216.
Berkshire Hathaway has a median target price of $490 per share. That implies 0% upside from its current share price of $490.
Meta Platforms has a median target price of $700 per share. That implies less than 1% downside from its current share price of $702.
Tesla has a median target price of $306 per share. That implies 7% downside from its current share price of $329.
Wall Street clearly sees Nvidia as the best trillion-dollar stock to buy right now. Here's what investors should know about the chipmaker.
Nvidia is a market leader in AI chips and networking gear
Nvidia is the market leader in data center graphics processing units (GPUs), chips used to accelerate artificial intelligence (AI) training and inference tasks. The company is also the market leader in InfiniBand networking equipment, the leading connectivity technology for back-end AI networks.
Importantly, Nvidia has struggled with two headwinds throughout the year. First, Chinese start-up DeepSeek developed sophisticated large language models using fewer GPUs than U.S. competitors, causing investors to worry demand would decline. Second, the Trump administration restricted the export of H20 GPUs built for the Chinese market, effectively preventing Nvidia from operating in the country.
Nvidia more or less put the first concern to rest with impressive first-quarter financial results that exceeded expectations on the top and bottom lines. Revenue increased 69% to $44 billion due to what CEO Jensen Huang characterized as "incredibly strong" demand for Nvidia AI infrastructure. And non-GAAP (adjusted) net income jumped 33% to $0.81 per diluted share.
However, while first-quarter results show robust demand, export controls still hurt Nvidia. The company took a $4.5 billion charge due to excess H20 inventory, and adjusted earnings would have increased 57% to $0.96 per diluted share had the Trump administration not imposed new restrictions. Huang also said the company will miss out on $8 billion in sales in the July-ending quarter.
Nevertheless, Morgan Stanley believes the downside related to export restrictions is fully priced into the stock and that Nvidia will eventually be able to participate in the Chinese market to some degree. "China is entirely derisked, at least for direct shipments, and we are optimistic that there will be some path to monetize at least a portion of that demand," analysts wrote in a recent note.
Grand View Research estimates the data center GPU market will expand at 28.5% annually through 2030, while spending across AI hardware, software, and services increases at 35.9% annually during the same period. Nvidia is exceptionally well positioned to benefit from that explosive growth.
Nvidia stock trades at a reasonable price
Wall Street expects Nvidia's adjusted earnings to increase at 40% annually through the fiscal year ending January 2027. That makes the current valuation of 45 times adjusted earnings look reasonable, especially when Nvidia beat the consensus estimate by an average of 4% in the last six quarters.
As a caveat, the semiconductor industry is cyclical, meaning Nvidia's sales tend to ebb and flow as companies intermittently invest in chips and other data center infrastructure. For instance, revenue growth could slow toward the beginning of fiscal 2027 as the company ramps up production of its next-generation Rubin GPU (slated to launch in the second half of next year).
However, investors should also bear in mind that Nvidia has a substantial opportunity in its often overlooked automotive and robotics segment, which currently accounts for less than 2% of total sales. Generative AI has been in the spotlight since ChatGPT launched in late 2022, but Huang says the "ChatGPT moment" for autonomous cars and robots is right around the corner.
Importantly, Nvidia has three computing platforms that address those markets: data center infrastructure to train models, a simulation engine to test those models, and embedded systems that handle on-board computing. Also, the company provides software tools that help developers build the necessary applications.
Here's the bottom line: Nvidia enjoys a leadership position in a quickly growing market, and shares trade at a reasonable valuation. The stock price may be volatile over relatively short periods (i.e., months) due to the cyclical nature of the industry, but Nvidia still has a long runway for growth as the physical AI (autonomous cars and robots) market takes shape.
Should you invest $1,000 in Nvidia right now?
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!*
Now, it's worth noting Stock Advisor 's total average return is791% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Trevor Jennewine has positions in Amazon, Nvidia, and Tesla. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, Taiwan Semiconductor Manufacturing, and Tesla. The Motley Fool recommends Broadcom and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
30 minutes ago
- Globe and Mail
How cutting down on meetings and ‘intentional serendipity' can improve your team's cohesion
Question: I feel like my team isn't clicking the way we should be. We went through some changes this past year, including a couple of layoffs and a move back into the office three days a week. Now, no one seems very happy to be here. As a team leader, how can I encourage more motivation and cohesion? We asked Jennifer Moss, international speaker, co-founder of the Work Better Institute and author of Why Are We Here?, to tackle this one: This is happening all over the place right now. It is very much what I'm hearing from a lot of leaders. When we have been given agency to do things in a certain way and then it is clawed back, our instinct as humans is to hold on to that sense of freedom, even at personal cost. We can be emotionally resistant and it is often subconscious. It's important for leaders to understand and validate that resistance. I think that we need to have more conversations about it with our teams. Maybe you're not working fully remote anymore, but are there other things that could increase your flexibility? Maybe it's not where you work, but how you want to work. Are there ways to job craft? To use more of your strengths so that you're working on what you love to do? The happier people are at work, the more they are going to get along with other people. Return to office mandates can actually reduce team cohesion and reduce community. Everyone is saying remote work is creating this loneliness epidemic. I say it's time poverty that is creating the loneliness epidemic. Microsoft reported that there was a 252 per cent increase in time spent in meetings for the average Teams user between February 2020 and February 2022. A 2023 survey by Slack found that more than two hours a day in meetings starts to decrease productivity. Let's think about how we can increase time wealth. Figure out how to cut down on meeting fatigue and how to create intentional serendipity. We used to have rituals. People thought it was forced fun; they would roll their eyes and say now I have to go into the break room and have this terrible slab cake and celebrate four birthdays. But what happened is it created these ad-hoc chats about the movie we saw last week, and that increased our connectivity with people. Now there's none of that. There are ways to slowly build morale. Maybe it's 20 minutes once a week of having lunch together. Great research out of Cornell University found that employees having lunch together changed retention, improved well-being and decreased safety risks. Leaders also need to celebrate more of the small wins every week. We need to get people feeling like, 'Today I did a good thing, this week I did a good thing, this month I did good thing.' And if you are going around and saying, 'This is a cool thing that my team did,' you are also protecting your team from layoffs because you're giving them visibility to the rest of the organization. That provides psychological safety and creates loyalty. The spillover is more cohesion, because when people are feeling good, they tend to be nicer to other people. 'I felt like a hamster on a wheel': Why some millennials are choosing micro-retirement According to Sumana Jeddy, a Calgary-based work wellness coach for large enterprises, micro-retirement is a 'strategic, intentional break' that helps individuals with recovery over a health issue or a significant personal experience; it can also redirect personal ambitions. Instead of waiting until 65 to stop working, micro-retirees are taking an extended work break in their 30s or 40s. They do whatever they can to recover and refocus over a three or four-year time period, then return refreshed to the same or a different job with some newly acquired skills and experience. Working long hours can change our brain – and not in a good way, study shows Previous research has found correlations between working long hours and other negative health outcomes, such as cardiovascular disease, burnout, anxiety and depression, but the researcher says this is the first study to observe physical changes to the brain. 'Our study extends this understanding by providing novel neurobiological evidence that chronic overwork directly correlates with structural changes in brain regions that control cognitive and emotional functions,' says Wanhyung Lee, a researcher in the department of preventive medicine at Chung-Ang University in Seoul, South Korea. These women are leading in male-dominated industries – and they're hiring all-women teams Annastacia Plaskos shadowed a contractor for several years before she felt she had the skills to set out on her own. Then, she launched Fix It Females, a home renovation business that does everything from house painting to drywalling to building. The business rapidly grew from three to nearly 40 employees within a few years – all of them women. 'For me, showing other women you can do this, that it is possible [is important],' she says. 'You can make the same amount of money that a male can in this industry. It is doable.'
National Post
33 minutes ago
- National Post
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
Article content Winner's lead therapy targets Parkinson's disease; platform addresses 6,000+ genetic disorders Neoclease gains access to MilliporeSigma's technologies and expert support to scale its AI-designed gene-editing platform The company has awarded 40+ startups globally through Advance Biotech Grant since 2014 Article content BURLINGTON, Mass. — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant. The Boston-based biotech startup develops AI-designed gene editing therapies for Parkinson's disease. Article content Article content 'We're committed to empowering biotech innovators who are advancing transformative modalities like gene editing,' said Sebastián Arana, Head of Process Solutions, Life Science business of Merck KGaA, Darmstadt, Germany. 'By combining Neoclease's AI-designed gene-editing platform with our technologies, regulatory expertise, and process support, we aim to help accelerate new treatments that minimize side effects and maximize effectiveness for patients.' Article content Neoclease's platform combines generative AI and synthetic biology to develop next-generation, precision gene-editing therapies. Neoclease's lead candidate, NCX-L2, is designed to slow or halt the progression of Parkinson's disease – a condition that currently has no disease-modifying treatments. More broadly, Neoclease's approach has the potential to address more than 6,000 monogenic diseases by targeting the root causes of illness rather than only managing symptoms. Article content As part of the grant, Neoclease will receive access to MilliporeSigma's products, technologies, and contract testing services, as well as expert consultation and training through the M Lab™ Collaboration Center and Emprove ® program. M Lab™ Collaboration Centers offer hands-on technical solutions and process optimization, while the Emprove ® Program simplifies risk management and regulatory compliance through quality products, detailed documentation, and dedicated support. These resources will support Neoclease in scaling its processes, optimizing manufacturing, and navigating regulatory requirements. Article content The Advance Biotech Grant Program, launched in 2014, reflects the ongoing commitment of the life science business of Merck KGaA, Darmstadt, Germany to supporting early-stage biotech companies developing innovative therapies for patients. To date, more than 40 companies worldwide have received grants and technical support across a wide range of therapeutic areas including cancer, neurological diseases, and cardiovascular disorders. The company will continue this global effort with upcoming grant awards in Asia-Pacific (October) and Europe, the Middle East, and Africa (November). Article content About the Life Science business of Merck KGaA, Darmstadt, Germany Article content The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Article content Around 62,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries. Article content The company holds the global rights to the name and trademark 'Merck' internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company's technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit Article content Article content Article content Article content Article content Article content
National Post
33 minutes ago
- National Post
QXO Announces Rachel Narveson as 2025 Female Roofing Professional of the Year
Article content The founder and CEO of Proficient Construction in Lake Elmo, MN earns a $10,000 prize Article content GREENWICH, Conn. — QXO, Inc. (NYSE: QXO) announced today that Rachel Narveson, Founder and CEO of Proficient Construction in Lake Elmo, MN, is the winner of its 2025 North American Female Roofing Professional of the Year program, an annual campaign celebrating the outstanding contributions, leadership, and professionalism of women in the roofing industry. Article content Article content Now in its fifth year, the program shines a spotlight on female roofing professionals who are making a difference through innovation, mentorship, safety and a commitment of excellence in their field. Narveson won in a nationwide public vote against four other accomplished finalists. Article content For over two decades, Narveson has been breaking barriers and leading Proficient Construction in transforming homes and businesses in Minnesota and Wisconsin with high-grade materials. Under Narveson's leadership, Proficient Construction earned a BuildZoom score of 113, placing it in the top 3% of Minnesota contractors. Known for her responsiveness, professional excellence, and unwavering commitment to customer satisfaction, she has earned the trust of crews, clients and her community. Article content Narveson uses her platform to champion positive social change and inspire others by supporting organizations like Renew Hope, which focuses on combating sex trafficking and aiding survivors. Article content QXO Chief Human Resources Officer Josephine Berisha said, 'Rachel's commitment to empowering others make her a powerful example for the next generation. We're proud to recognize her contributions to the industry and amplify the stories of women shaping the future of roofing across North America.' Article content As the 2025 honoree, Narveson earns a $10,000 prize, one year free of the Leap platform, a year of membership to National Women in Roofing, and one ticket to the 2026 NWIR Days event. Article content 'It's an honor to be recognized by my peers and the broader roofing community,' said Narveson. 'This award wouldn't be possible without the extraordinary women in our industry empowering one another and driving the industry forward. I hope my story inspires other women and other young professionals to pursue their passions.' Article content The four other finalists who will each receive funding to support their professional development are: Article content This year's finalists were selected from over 1,000 nominations across the US and Canada. The finalist selection committee was made up of female leaders across the industry including the Chair of National Women in Roofing, the publisher of Roofing Contractor, the president of female roofers and select leaders from QXO. Article content Article content Article content Article content Article content Contacts Article content Media Contacts: Article content Article content Joe Checkler Article content Article content Article content 203-609-9650 Article content Article content Article content
